28bio
28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today’s neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the
development of brain organoid technology and engineered human cognition.
